Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-12-08

Clinical Trial Update: Study to Compare U0267 Against Vehicle in Subjects With Plaque-type Psoriasis Two of Two Phase 3 Studies [Phase 3]

View source ↗

Summary

Two Phase 3 studies evaluating U0267 against vehicle in plaque-type psoriasis have completed, with results posted in December 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • U0267

Snippet

Sponsor: Stiefel, a GSK Company | Conditions: Psoriasis | Phase 3 | Status: COMPLETED | Results posted: 2010-12-08